Yvonne Greenstreet, Chief Executive Officer at ALNYLAM PHARMACEUTICALS, INC. (ALNY), sold 10,045 shares at $249.60 ($2.5M) on 2024-11-26, disclosed to the SEC on 2024-11-27.
Open-market sale of $2.5M ALNY by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $247.77 | 93 | $23K | 0.9% |
| 2 | $249.60 | 762 | $190K | 7.5% |
| 3 | $249.60 | 762 | $190K | 7.5% |
| 4 | $250.68 | 1,131 | $284K | 11.2% |
| 5 | $250.68 | 1,131 | $284K | 11.2% |
| 6 | $251.42 | 2,933 |
| $737K |
| 29.3% |
| 7 | $251.42 | 2,933 | $737K | 29.3% |
| 8 | $252.27 | 300 | $76K | 3.0% |
| Total | $250.97 avg | 10,045 | $2.5M | 100% |
| Filing → |
| ALNY | SELL | 2026-02-17 | $2.2M | — | Filing → |
| ALNY | SELL | 2026-01-14 | $3.5M | — | Filing → |
| ALNY | SELL | 2025-11-14 | $23.2M | — | Filing → |